Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Amine Chamakhi is a leading figure in the advancement of minimally invasive pancreatic surgery, with a focused expertise in left pancreatectomy. His most impactful work centers on understanding and mitigating the risks of conversion from minimally invasive to open surgery—a critical challenge occurring in 15-30% of cases. Dr. Chamakhi’s major contribution is the development of a predictive Conversion Risk Score (CRS), a practical tool designed to identify patients at highest risk for conversion. This work, published in 2025 and already garnering 4 citations, directly addresses the need for better preoperative planning and patient counseling. By rigorously analyzing risk factors and assessing the link between conversion and severe postoperative complications, his research provides actionable insights that can improve surgical outcomes and patient safety. Dr. Chamakhi’s work is essential reading for surgeons and researchers aiming to refine minimally invasive techniques, reduce operative risks, and enhance the evidence base for pancreatic surgery.